HOTH News and Press, Hoth Therapeutics Inc. From 11/14/23

Hoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Development of Hoth's Cancer Fighting HT-KIT PR Newswire Hoth intends to continue development under Orphan Drug Designation NEW YORK , Nov. 14, 2023 /PRNewswire/ -- Ho...

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

Hoth Therapeutics Inc. (HOTH) is expected to report for Q1 2024

2023-10-26 13:48:39 ET More on BioVie, Cognition, etc. BioVie: Bullish Signals From Blinded Data Presentation (Rating Upgrade) Prothena: Switching From 'Hold' To 'Buy' On Lead Alzheimer's Drug Promise BioVie: Well-Powered Phase 3 Trial In Alzheimer's Could Greatly Be...

Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug Discovery PR Newswire The new wholly owned subsidiary will screen for rare disease therapeutics. NEW YORK , Oct. 5, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. (NAS...

FDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT, Treatment for Cancer Patients PR Newswire NEW YORK , Oct. 2, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the Pre-IND m...

Hoth Therapeutics Announces Closing of $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules PR Newswire NEW YORK , Sept. 15, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) ("Hoth" or the "Company"), a patient-focused bioph...

2023-09-14 08:35:01 ET Losers: BIOLASE ( BIOL ) -44% on prices $4.5M stock offering . Bionomics Limited ( BNOX ) -20% announces update on the α7 Nicotinic Acetylcholine Receptor positive allosteric modulator collaboration with MSD. Simpple ( SP...

2023-09-13 14:31:04 ET More on Hoth Therapeutics Seeking Alpha’s Quant Rating on Hoth Therapeutics Historical earnings data for Hoth Therapeutics Financial information for Hoth Therapeutics For further details see: Hoth stock tumbles on $2.9M direc...

2023-09-13 14:16:14 ET Gainers: Avalo Therapeutics ( AVTX ) +56% . ZyVersa Therapeutics ( ZVSA ) +41% . Rocket Pharmaceutical ( RCKT ) +35% . Vigil Neuroscience ( VIGL ) +31% . Aspira Women's Health ( AWH ) +27% . Novo Integr...